XTLB XTL Biopharmaceuticals
- 1.760
- -0.090-4.86%
XTL Biopharmaceuticals News
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 20-F: FY2023 Annual Report
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K/A: Report of foreign private issuer [Rules 13a-16 and 15d-16] (Amendment)
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 20-F: FY2022 Annual Report
XTL Biopharmaceuticals | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Analysis
Price Target
No Data
No Data